598 - Behind the Scenes of Medical Software in Australia: MSIA’s Role and Priorities

Why It Matters

MSIA’s coordination of policy, regulation, and industry collaboration ensures Australian health‑tech firms can innovate safely, especially as AI becomes integral to medical software.

Key Takeaways

• MSIA represents over 95% of Australian health software platforms.
• Association bridges government policy, regulation, and industry collaboration.
• MSIA facilitated rapid interoperability, delivering electronic script in ten days.
• New voluntary AI governance code ensures transparency, privacy, and security.
• Matchmaking events connect members with government, partners, and investors.

Summary

The Talking Health Tech podcast episode spotlights the Medical Software Industry Association (MSIA), the umbrella body for virtually all health‑software providers in Australia. Founded in the late 1990s to tame a fragmented market, MSIA now operates as a company limited by guarantee and claims that more than 95% of health transactions in the country run on its members’ platforms, from virtual‑care tools to pharmacy dispensing systems.

Emma Hosac explains how MSIA acts as the conduit between a heavily regulated environment—over 50 agencies including the TGA, ASC, and privacy regulators—and the private sector. The association negotiates policy, shapes government consultations, and coordinates industry‑wide initiatives. A hallmark achievement was the ten‑day rollout of a fully electronic prescription system in 2020, a feat she describes as “10 days instead of 10 years.”

The conversation also highlights MSIA’s proactive stance on emerging technologies. In response to the AI surge, the group helped craft a voluntary governance code for unregulated AI‑driven medical software, emphasizing clinical oversight, data transparency, and security. Hosac notes that this code dovetails with the national AI plan and fills gaps regulators cannot keep pace with. Regular networking events and a 30%‑time matchmaking role further help members overcome bureaucratic roadblocks and find partners.

For health‑tech firms, engagement with MSIA is portrayed as essential to avoid “driving in the dark.” The association’s influence accelerates interoperability, mitigates regulatory risk, and provides a trusted platform for AI governance—factors that can determine a company’s survival and scalability in Australia’s tightly regulated health ecosystem.

Original Description

In this episode of Talking HealthTech, Peter Birch sits down with Emma Hossack, CEO of the Medical Software Industry Association (MSIA), to unpack the often overlooked role of software in keeping Australia’s healthcare system running.

The conversation explores how MSIA represents and supports the organisations building the digital infrastructure behind everyday care, and why their work is more critical than most people realise.

Peter and Emma dive into the origins and purpose of MSIA, its growing influence on health software policy, and how it is helping shape the governance of emerging technologies like artificial intelligence.

They also discuss the increasing weight of regulation, the tension between compliance and innovation, and the funding challenges facing local software providers.

The discussion offers a practical look at the people and systems working behind the scenes, and why stronger collaboration between government, industry, and clinicians will be essential for the future of digital health in Australia.

Key Takeaways

💡 Over 95% of Australian healthcare operates on MSIA member platforms, making their work foundational to the sector.

🔗 MSIA acts as a bridge between industry and government, shaping and supporting health software policy and regulation.

🧑‍💻 Artificial intelligence in health tech is a major focus, with MSIA developing a voluntary code for unregulated products and leading industry-wide collaboration on AI governance.

📊 Regulatory compliance demands have increased significantly, with some software providers now spending up to 80% of their effort on meeting these requirements.

🤝 MSIA facilitates collaboration, networking, and knowledge sharing through events, monthly member sessions, matchmaking, and support for overcoming industry roadblocks.

Timestamps

00:00 — Introduction to MSIA

04:00 — Industry impact and membership

07:00 — COVID-19 response and digital prescribing

12:41 — AI in healthcare and MSIA’s voluntary code

19:40 — Regulation vs. innovation in development

26:11 — Funding, training, and recent challenges

38:37 — Upcoming priorities and activities

--------

Want to keep the conversation going?

The full article and extended show notes for this episode are available inside the THT+ Community here: https://community.talkinghealthtech.com/c/podcast/598-behind-the-scenes-of-medical-software-in-australia-msia-s-role-and-priorities-70fdc19f-c6e2-41f9-bdb9-a5c894f2eeed

In the THT+ Community, our members keep the discussion going, share perspectives, and unpack what this episode actually means in practice with other people working in healthtech.

If you’re enjoying the show and want access to full articles, episode discussions, meetups, and member-only content, you can learn more about becoming a THT+ Solo Member here: https://talkinghealth.tech/solo_shownotes.

And if this episode was useful, leaving a review or sharing it with someone in the industry always helps.